Quantum Biopharma (QNTM) to Release Quarterly Earnings on Thursday

Quantum Biopharma (NASDAQ:QNTMGet Free Report) is expected to be releasing its earnings data before the market opens on Thursday, March 27th. Analysts expect Quantum Biopharma to post earnings of ($0.80) per share for the quarter.

Quantum Biopharma Stock Up 5.6 %

Shares of QNTM stock opened at $5.86 on Wednesday. Quantum Biopharma has a 12 month low of $2.70 and a 12 month high of $18.00. The company has a market cap of $11.25 million, a PE ratio of -0.38 and a beta of 0.37. The business’s 50 day moving average is $5.92 and its two-hundred day moving average is $4.97.

About Quantum Biopharma

(Get Free Report)

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company’s three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS.

Featured Articles

Earnings History for Quantum Biopharma (NASDAQ:QNTM)

Receive News & Ratings for Quantum Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.